Variant report
Variant | nsv969951 |
---|---|
Chromosome Location | chr5:28742141-28753068 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs557844658 | chr5:28742157-28742158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs190849297 | chr5:28742209-28742210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs183472710 | chr5:28742216-28742217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs151094094 | chr5:28742224-28742225 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs140115778 | chr5:28742242-28742243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs570957903 | chr5:28742253-28742254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs72758515 | chr5:28742262-28742263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs4461647 | chr5:28742269-28742270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs528803746 | chr5:28742284-28742285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs188242047 | chr5:28742286-28742287 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs545598301 | chr5:28742291-28742292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs562123301 | chr5:28742311-28742312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs529358714 | chr5:28742313-28742314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs551140279 | chr5:28742346-28742347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs569061991 | chr5:28742389-28742390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs553069545 | chr5:28742394-28742395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs538427492 | chr5:28742402-28742403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs116700613 | chr5:28742421-28742422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs115053529 | chr5:28742435-28742436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs551629834 | chr5:28742440-28742441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs143779973 | chr5:28742458-28742459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs541853676 | chr5:28742546-28742547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs115828454 | chr5:28742553-28742554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs555018570 | chr5:28742714-28742715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs567303206 | chr5:28742739-28742740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs537540321 | chr5:28742805-28742806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs193190339 | chr5:28742812-28742813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs575412496 | chr5:28742861-28742862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs376772492 | chr5:28742869-28742870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs558346207 | chr5:28742991-28742992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs113046927 | chr5:28743034-28743035 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs540924884 | chr5:28743091-28743092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs146705886 | chr5:28743097-28743098 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs531239017 | chr5:28743103-28743104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs544701767 | chr5:28743122-28743123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs1423292 | chr5:28743137-28743138 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs533485045 | chr5:28743149-28743150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs551249552 | chr5:28743158-28743159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs13168683 | chr5:28743166-28743167 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs575988207 | chr5:28743179-28743180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs527590222 | chr5:28743191-28743192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs549301100 | chr5:28743311-28743312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs1423291 | chr5:28743348-28743349 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs184743631 | chr5:28743371-28743372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs16898058 | chr5:28743380-28743381 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs140285163 | chr5:28743406-28743407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs570976010 | chr5:28743447-28743448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs111606863 | chr5:28743509-28743510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs541389355 | chr5:28743551-28743552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs7705028 | chr5:28743637-28743638 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Lung cancer | 16740712 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:28737800-28743200 | Weak transcription | Hela-S3 | cervix |
2 | chr5:28743200-28743600 | Enhancers | Fetal Heart | heart |
3 | chr5:28743200-28743800 | Enhancers | Hela-S3 | cervix |
4 | chr5:28743200-28744000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
5 | chr5:28743400-28743800 | Enhancers | Fetal Stomach | stomach |
6 | chr5:28743400-28744200 | Enhancers | NH-A | brain |
7 | chr5:28752800-28753000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |